Spots Global Cancer Trial Database for Ribomustin in the Second Line Therapy of Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Ribomustin in the Second Line Therapy of Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma
Official Title: Observational Program for Evaluation of Ribomustin and Rituximab Combined Therapy With Following Rituximab Maintenance of Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma
Study ID: NCT02072967
Conditions
Study Description
Brief Summary: Prospective multicenter observational non-interventional study to assess routine clinical practice of Bendamustine use in the second line therapy of relapsed or refractory indolent B-cell non-Hodgkin's lymphoma
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
City Clinical Hospital #8, Barnaul, , Russian Federation
Chelyabinsk Regional Oncology Dispensary/15, Chelyabinsk, , Russian Federation
Vologda Regional Clinical Hospital #2, Cherepovets, , Russian Federation
Regional Oncology Dispensary/35, Irkutsk, , Russian Federation
Irkutsk Regional Сlinical Hospital/31, Irkutsk, , Russian Federation
Kaluga Regional Clinical Hospital/02, Kaluga, , Russian Federation
District Cancer center od Khanty -Mansiysk, Khanty-Mansiysk, , Russian Federation
City Сlinical Hospital#7/25, Krasnoyarsk, , Russian Federation
Regional Сlinical Hospital/12, Krasnoyarsk, , Russian Federation
Adygei Regional Clinical Oncology Dispensary/11, Maykop, , Russian Federation
Scientific Medical Surgical Center n.a.I.V.Pyrogov/17, Moscow, , Russian Federation
European Medical Center, Moscow, , Russian Federation
RONC n.a.N.N.Blokhin/18, Moscow, , Russian Federation
Сentral Clinical Hospital n.a. Semashko N.A./30, Moscow, , Russian Federation
Moscow Scientific Research Oncology Institution n.a.P.A. Gertzen/37, Moscow, , Russian Federation
Central Clinical Hospital of Department of Presidential Affairs, Moscow, , Russian Federation
Municipal Сlinical Hospital № 12/20, Nizhniy Novgorod, , Russian Federation
Novosibirsk State Regional Clinical Hospital/23, Novosibirsk, , Russian Federation
Medical Radiology Scientific Center/38, Obninsk, , Russian Federation
Omsk Regional Clinical Hospital/40, Omsk, , Russian Federation
City Сlinical Hospital#1 n.a.Kabanov A.N./13, Omsk, , Russian Federation
Orenburg State Medical Academy/05, Orenburg, , Russian Federation
Rostov Scientific Research Oncology Institution/01, Rostov-on-Don, , Russian Federation
City Сlinical Oncological Dispensary/22, Saint-Petersburg, , Russian Federation
City Сlinical Hospital#31/08, Saint-Petersburg, , Russian Federation
Military-Medical Academy n.a. Kirova, Saint-Petersburg, , Russian Federation
Scientific Research Oncological Institution n.a. Petrov N.N./29, Saint-Petersburg, , Russian Federation
Samara State Medical University' Clinics/36, Samara, , Russian Federation
Road Clinical Hospital on Rostov-Main Station OAO RZhD/06, Smolensk, , Russian Federation
Surgut Regional Clinical Hospital, Surgut, , Russian Federation
Tula Regional Clinical Hospital/21, Tula, , Russian Federation
Volgograd Regional Clinical Oncology Dispensary#1/10, Volgograd, , Russian Federation
Vologda Regional Clinical Hospital/39, Vologda, , Russian Federation
Yekaterinburg Regional Clinical Hospital #1, Yekaterinburg, , Russian Federation
Sakhalin Regional Oncology Dispensary/32, Yuzhno-Sakhalinsk, , Russian Federation
Contact Details
Name: Clinical Study Manager
Affiliation: Astellas Pharma Europe B.V.
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
